accountApril 5 (Bloomberg) -- Johnson & Johnson and Bayer AG���s experimental pill Xarelto worked as well as a standard injection to prevent blood clots from forming in critically ill hospital patients, though it raised bleeding rates in a...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to J&J, Bayer���s Xarelto Curbs Clots, Raises Bleeding Risk in Study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account